China Universal Asset Management »

Editas Medicine shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Editas Medicine (EDIT) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Editas Medicine

Tip: Access up to 7 years of quarterly data

All positions including Editas Medicine held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Editas Medicine by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $54k 16k 3.41
2024-06-30 $45k 9.7k 4.67
2024-03-31 $117k 16k 7.42
2023-12-31 $96k 9.5k 10.13
2023-09-30 $16k 2.1k 7.80
2023-06-30 $7.4k 905 8.23
2023-03-31 $6.8k 935 7.25
2022-12-31 $6.2k 698 8.87
2022-09-30 $8.0k 644 12.42

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms Inc-class A Common Stock (META)
Broadcom Common Stock (AVGO)
Vertex Pharmaceuticals Common Stock (VRTX)
Alphabet Inc-cl A Common Stock (GOOGL)
Gilead Sciences Common Stock (GILD)
Amgen Common Stock (AMGN)
Regeneron Pharmaceuticals Common Stock (REGN)
Taiwan Semiconductor-sp Adr (TSM)
Netflix Common Stock (NFLX)
Servicenow Common Stock (NOW)
Visa Inc-class A Shares Common Stock (V)

View all positions for China Universal Asset Management

Top funds holding Editas Medicine

Vanguard Group
BlackRock
BlackRock
Deep Track Capital
State Street Corporation
Dimensional Fund Advisors
Geode Capital Management
Avidity Partners Management
Goldman Sachs Group
Pictet Asset Management Holding SA
Morgan Stanley
Woodline Partners
Bank of America Corporation
Jane Street
Two Sigma Advisers

View all funds holding Editas Medicine